FTT 0.00% 0.5¢ factor therapeutics limited

run coming?, page-70

  1. 9,595 Posts.
    lightbulb Created with Sketch. 330
    Justsayingok and Rock57,

    Fair enough. I too was a TIS holder. I gained some and I lost some.

    But one has to look at the company now imho.

    Many times on the asx we have seen stocks make some bad decisions or have failures and plummet in share price. Then there are changes made to the managers and business and the company turns around. These are times where large sums of money can be made.

    Use neu as an example. sp in the 50c's and 60c's. But then they used Springtree for funding. Springtree would be issued shares for cash, but then sell those shares on the market. Hence the sp was driven lower. Then they failed with their Glypromate phase 3 clinical trial and their sp was around 1c with no funds at all.

    But then comes the change. Some new board members and managers and a large fund raising at 1.3c. This was the buy time for me. The time to back up the truck and buy millions. The past failures are now irrelevant, there's a new team and the funding to develop further.

    Now it took a while for the sp to move up, as the dead wood needed to be cleared out. That dead wood refers to those long term holders who don't share this new enthusiasm, they are just happy to get some more money back than the 1c it was. So they sell out at 1.6c, 2c, 2.5c who knows.

    But the new holders are in at a low price, and gain a good holding.

    neu is now over 15c (they had a consolidation 20 for 1, so $3 now is equivalent to 15c before).

    For me this is where ftt is now.

    There's a new management team and board members. There's a new path going forward.

    So if we look at ftt today as an investment and forget the past, which is now irrelevant as those people and the path has changed - ftt has:

    * enough funding for trial results and more.
    * has what could be a very valuable and sell-able product.
    * appears to be doing very well in the clinical trial, going on the data that we have.
    * has near term value inflection points - clinical trial results and partnering/take over.
    * has further upside as there are other indication available for our drug.

    The sad thing is, as I said before, many long term holders won't see this benefit. They perhaps invested $40k and bought 100,000 shares at 40c ages ago. Then when the sp rises to say 6c, they sell out and end with a $34k loss.

    Somebody new puts in $40k and buys 1,000,000 shares at 4c. Then sells them at 30c and pockets a $260k profit.

    This kind of thing happens so often.

    Of course one never knows and there is always risk. But if you believe in the product just research the stock as it is today and going forward - not looking backwards - as the past doesn't count any more (as those people and that direction is gone).

    All imho.

    ps. I am loading the truck on ftt now. I added 500k shares today.
 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.